glp-1 obesity drug updates today Dozens of new drugs are coming: these are the ones to watch How to Invest in GLP-1

A large retrospective study by Best et al compared patients treated with exenatide, a GLP-1 analog, to those treated with other glucose-lowering drugs, and found a 20% decrease in cardiovascular events

Munir K

These medications require a prescription and professional supervision, as potential side effects might include nausea, diarrhea, constipation, or abdominal discomfort

Lancet (2006) 368:1696705

Thus, this narrative review explores six commonly used classes of DPP4is, focusing mainly on their features, mechanism of action, advantages, and side effects in comparison with other antidiabetic agents and potential developments using an in silico approach

[DOI] [PMC free article] [PubMed] [Google Scholar] 82.Abdali D., Samson S.E., Grover A.K